- Home
- IMNM vs NEXN Comparison
IMNM vs NEXN Comparison
Compare IMNM & NEXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- NEXN
- Stock Information
- Founded
- IMNM 2006
- NEXN 2007
- Country
- IMNM United States
- NEXN Israel
- Employees
- IMNM N/A
- NEXN N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- NEXN Computer Software: Programming Data Processing
- Sector
- IMNM Health Care
- NEXN Technology
- Exchange
- IMNM Nasdaq
- NEXN Nasdaq
- Market Cap
- IMNM 585.5M
- NEXN 645.6M
- IPO Year
- IMNM 2020
- NEXN 2021
- Fundamental
- Price
- IMNM $11.08
- NEXN $9.75
- Analyst Decision
- IMNM Strong Buy
- NEXN Buy
- Analyst Count
- IMNM 5
- NEXN 7
- Target Price
- IMNM $28.60
- NEXN $10.43
- AVG Volume (30 Days)
- IMNM 1.0M
- NEXN 121.3K
- Earning Date
- IMNM 03-27-2025
- NEXN 03-05-2025
- Dividend Yield
- IMNM N/A
- NEXN N/A
- EPS Growth
- IMNM N/A
- NEXN N/A
- EPS
- IMNM N/A
- NEXN 0.09
- Revenue
- IMNM $10,129,000.00
- NEXN $349,109,000.00
- Revenue This Year
- IMNM N/A
- NEXN $7.66
- Revenue Next Year
- IMNM N/A
- NEXN $7.80
- P/E Ratio
- IMNM N/A
- NEXN $44.87
- Revenue Growth
- IMNM N/A
- NEXN 1.55
- 52 Week Low
- IMNM $8.97
- NEXN $4.61
- 52 Week High
- IMNM $30.96
- NEXN $10.94
- Technical
- Relative Strength Index (RSI)
- IMNM 54.91
- NEXN 47.88
- Support Level
- IMNM $10.29
- NEXN $9.21
- Resistance Level
- IMNM $11.43
- NEXN $9.95
- Average True Range (ATR)
- IMNM 0.77
- NEXN 0.27
- MACD
- IMNM 0.18
- NEXN -0.05
- Stochastic Oscillator
- IMNM 85.23
- NEXN 44.08
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About NEXN Nexxen International Ltd. American Depository Shares
Nexxen International Ltd empowers advertisers, agencies, publishers, and broadcasters to utilize video and connected TV. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with advanced and exclusive data at its core.